The LLS Blog
Read about survivors, research, fundraising and advocacy.
Meet the Researcher: Charlene Liao, PhD
In honor of Asian American and Pacific Islander Heritage Month in May, LLS is highlighting the stories of volunteers, healthcare professionals, researchers, patients, survivors, and advocates from across our community. Recently, we caught up with Charlene Liao, Ph.D., Co-Founder, President, and Chief Executive Officer of Immune-Onc Therapeutics, a new LLS Therapy Acceleration Program® (LLS TAP) partner.
MEET THE RESEARCHER: Dr. Christopher R. Flowers
In this Q&A, we are highlighting Dr. Christopher R. Flowers, MD, chair of Lymphoma and Myeloma at The University of Texas MD Anderson Cancer Center and LLS National Board Member. Later this week, Dr. Flowers will be speaking on a timely panel about diversity in hematology clinical trials at AACR 2021.
Because You Volunteer, Your Impact Creates a Ripple Effect
At The Leukemia & Lymphoma Society (LLS), volunteers are our superheroes. Learn about the impact our volunteers help make possible in honor of National Volunteer Week 2021.
FDA Approval of New Treatment Option for Children with Secondary Acute Myeloid Leukemia is a Welcome Step Forward
Here at The Leukemia & Lymphoma Society (LLS), we applaud every advance for children with blood cancers.
FDA Approves Novel Car T-Immunotherapy for the Treatment of Multiple Myeloma
Chimeric Antigen Receptor (CAR) T cell-therapy is on a roll. Today marks the seventh approval of CAR T therapy since the first approval in 2017.